Insurance prices of innovative drugs in Korea are more expensive than advanced countries

Published: 2002-09-30 06:58:00

Updated: 2002-09-30 06:58:00

The domestic insurance price of some innovative drugs, being more superior to the existing drugs in terms of efficacy and toxicity, is higher than foreign counterparts, a lawmaker said on September 25.

During the recent parliamentary inspection to the Health Insurance Review Agency (HIRA), Rep. Kim Sung-soon said that the insurance prices of currently marketed 12 innovative drugs in Korea ar...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.